vs
Side-by-side financial comparison of Bandwidth Inc. (BAND) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Bandwidth Inc. is the larger business by last-quarter revenue ($208.8M vs $207.8M, roughly 1.0× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 1.9%, a 55.5% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-1.0M).
Bandwidth Inc. is a communications platform as a service company. It sells software application programming interfaces for voice, text messaging and emergency services, using its own global IP voice network.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BAND vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.8M | $207.8M |
| Net Profit | $4.0M | $119.2M |
| Gross Margin | 37.3% | — |
| Operating Margin | 60.5% | 52.2% |
| Net Margin | 1.9% | 57.4% |
| Revenue YoY | 20.1% | — |
| Net Profit YoY | 200.0% | 330.1% |
| EPS (diluted) | $-0.08 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $208.8M | — | ||
| Q4 25 | $207.7M | — | ||
| Q3 25 | $191.9M | $207.8M | ||
| Q2 25 | $180.0M | — | ||
| Q1 25 | $174.2M | — | ||
| Q4 24 | $210.0M | — | ||
| Q3 24 | $193.9M | $0 | ||
| Q2 24 | $173.6M | $0 |
| Q1 26 | $4.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | $119.2M | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-3.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $413.0K | $-51.8M | ||
| Q2 24 | $4.1M | $-52.8M |
| Q1 26 | 37.3% | — | ||
| Q4 25 | 37.6% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 39.8% | — | ||
| Q1 25 | 41.0% | — | ||
| Q4 24 | 36.4% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 37.3% | — |
| Q1 26 | 60.5% | — | ||
| Q4 25 | -1.9% | — | ||
| Q3 25 | -1.0% | 52.2% | ||
| Q2 25 | -2.1% | — | ||
| Q1 25 | -2.7% | — | ||
| Q4 24 | -1.3% | — | ||
| Q3 24 | -0.5% | — | ||
| Q2 24 | -3.5% | — |
| Q1 26 | 1.9% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.6% | 57.4% | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -2.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 2.3% | — |
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $-0.10 | — | ||
| Q3 25 | $-0.04 | $1.33 | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.01 | $-0.60 | ||
| Q2 24 | $-0.17 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.7M | $1.1B |
| Total Assets | $984.2M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $47.3M | — | ||
| Q4 25 | $111.3M | — | ||
| Q3 25 | $80.4M | $786.9M | ||
| Q2 25 | $68.1M | — | ||
| Q1 25 | $41.7M | — | ||
| Q4 24 | $83.8M | — | ||
| Q3 24 | $79.9M | $920.0M | ||
| Q2 24 | $76.4M | $701.7M |
| Q1 26 | $405.7M | — | ||
| Q4 25 | $400.0M | — | ||
| Q3 25 | $392.7M | $1.1B | ||
| Q2 25 | $384.5M | — | ||
| Q1 25 | $345.4M | — | ||
| Q4 24 | $312.5M | — | ||
| Q3 24 | $336.6M | $1.2B | ||
| Q2 24 | $307.4M | $931.7M |
| Q1 26 | $984.2M | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $964.4M | — | ||
| Q4 24 | $989.2M | — | ||
| Q3 24 | $1.0B | $1.2B | ||
| Q2 24 | $1.0B | $973.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | $-1.0M | $142.2M |
| FCF MarginFCF / Revenue | -0.5% | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $38.6M | — | ||
| Q3 25 | $22.2M | $142.2M | ||
| Q2 25 | $31.7M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $36.5M | — | ||
| Q3 24 | $20.5M | $-49.2M | ||
| Q2 24 | $24.4M | $-32.9M |
| Q1 26 | $-1.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
| Q1 26 | -0.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.55× | — | ||
| Q2 24 | 6.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
